ArticleScientific reports2026
Explainable machine learning prediction of tracheostomy after craniotomy for supratentorial intracerebral hemorrhage.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate prediction of tracheostomy after craniotomy for supratentorial intracerebral hemorrhage (sICH) remains challenging. This study aimed to develop, externally validate, and interpret a machine learning model for individualized risk prediction. A retrospective multicenter cohort was constructed, including 738 patients from Weifang People's Hospital and 186 from Weifang Hospital of Traditional Chinese Medicine who underwent craniotomy between January 2017 and December 2024. Predictor variables were screened using least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression. Logistic regression, random forest, and extreme gradient boosting (XGBoost) models were trained with repeated 10-fold cross-validation and assessed for discrimination, calibration, and clinical utility. Five key predictors were identified: Glasgow Coma Scale, age, hematoma volume, operative time, and serum bicarbonate. In external validation, XGBoost demonstrated the most balanced and robust performance, with an AUROC of 0.86 and a Brier score of 0.15, and showed superior net benefit on decision curve analysis. SHapley Additive exPlanations confirmed clinical plausibility, and a web-based dynamic nomogram was developed for individualized prediction. This explainable XGBoost model provides reliable and interpretable estimation of postoperative tracheostomy risk, facilitating evidence-based perioperative decision-making and resource allocation in neurocritical care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.